Background: Correlations between upright CT and pulmonary function test (PFT) measurements, and differences in lung/lobe/airway volumes between supine and standing positions in patients with chronic obstructive pulmonary disease (COPD) remain unknown. Objectives: The study aimed to evaluate correlations between lung/airway volumes on both supine and upright CT and PFT measurements in patients with COPD, and compare CT-based inspiratory/expiratory lung/lobe/airway volumes between the two positions. Methods: Forty-eight patients with COPD underwent both conventional supine and upright CT in a randomized order during inspiration and expiration breath-holds, and PFTs within 2 h. We measured the lung/lobe/airway volumes on both CT. Results: The correlation coefficients between total lung volumes on inspiratory CT in supine/standing position and PFT total lung capacity and vital capacity were 0.887/0.920 and 0.711/0.781, respectively; between total lung volumes on expiratory CT in supine/standing position and PFT functional residual capacity and residual volume, 0.676/0.744 and 0.713/0.739, respectively; and between airway volume on inspiratory CT in supine/standing position and PFT forced expiratory volume in 1 s, 0.471/0.524, respectively. Inspiratory/expiratory bilateral upper and right lower lobe, bilateral lung, and airway volumes were significantly higher in the standing than supine position (3.6–21.2% increases, all p < 0.05); however, inspiratory/expiratory right middle lobe volumes were significantly lower in the standing position (4.6%/15.9% decreases, respectively, both p < 0.001). Conclusions: Upright CT-based volumes were more correlated with PFT measurements than supine CT-based volumes in patients with COPD. Unlike other lobes and airway, inspiratory/expiratory right middle lobe volumes were significantly lower in the standing than supine position.

Chronic obstructive pulmonary disease (COPD) is a generally treatable and preventable disease characterized by persistent respiratory symptoms and limited air flow [1], representing the third leading cause of death worldwide [2]. The pulmonary function test (PFT) is the gold standard for diagnosing and staging the severity of COPD; however, the role of computed tomography (CT) has been expanded both in clinical practice and in research [3]. As of June 2022, there have been more than 500 million confirmed coronavirus disease 2019 cases and at least 6 million deaths worldwide [4]. Although PFTs are essential for COPD diagnosis and management, many PFT laboratories significantly reduced their testing capacity to reduce the spread of coronavirus disease 2019 [5]. Therefore, from a clinical perspective, an alternative to conventional PFTs would be desirable in situations where PFTs cannot be performed, such as an infectious disease pandemic [5].

An upright 320-detector-row CT scanner has recently been developed to assess the three-dimensional anatomy of the human body in the upright position [6]. This scanner enables the acquisition of isotropic volumetric data (0.5-mm voxel size) for the whole chest in approximately 5 s [7, 8]. A previous study reported that upright CT could predict PFT measurements, such as total lung capacity, functional residual capacity, and inspiratory capacity, more reliably than conventional supine CT in a volunteer cohort without any symptoms [8]. Although several previous studies have evaluated the correlation of lung volumes between conventional supine CT and PFT [9-11], to the best of our knowledge, no clinical study has evaluated the correlation between upright CT volumes and PFT measurements in patients with COPD. Furthermore, to our knowledge, no study has accurately evaluated the volume of each lung lobe in the standing position in patients with COPD, nor the differences in unilateral lung and lobe volumes between the supine and standing positions. PFTs are performed in the upright position; thus, we hypothesized that compared with supine CT, upright CT-based volumes would be more correlated with PFT measurements in patients with COPD, and upright CT could be a potential alternative to PFTs. We also hypothesized that each lobe volume in patients with COPD would be different between the supine and standing positions because the gravity direction in relation to the chest differs between the positions.

This study aimed to evaluate the correlations between lung/airway volumes on both supine and upright CT and PFT measurements in patients with COPD. Moreover, we aimed to compare CT-based inspiratory/expiratory lung, lobe, and airway volumes between the supine and standing positions.

Study Population

This prospective crossover study was approved by the Keio University School of Medicine Ethics Committee (No. 20160385) and was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all patients (UMIN Clinical Trials Registry (UMIN-CTR): UMIN000026587). From August 2018 to September 2019, 51 consecutive patients with known COPD, who were scheduled for clinical CT examination, were considered for inclusion in this study. The exclusion criteria were as follows: age <20 years (n = 0); pregnancy or unknown pregnancy status in patients with childbearing potential (n = 0); inability to undergo CT in the standing position (n = 0); unwillingness to provide written informed consent (n = 0); or forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) >70% on the same day of the upright and supine CT examinations (n = 3), as this contrasts with the diagnostic criteria for COPD [1]. The remaining 48 patients were included in this study (Fig. 1). The data of the 48 enrolled patients were analyzed in a previous study that evaluated the airway luminal areas [12] but not lung, lobe, and airway volumes. COPD was classified into spirometric grades 1–4 in accordance with the global initiative for chronic obstructive lung disease (GOLD) recommendations using the corresponding percent predicted FEV1 [1].

Fig. 1.

Flowchart of participant inclusion and exclusion. COPD, chronic obstructive pulmonary disease; CT, computed tomography; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.

Fig. 1.

Flowchart of participant inclusion and exclusion. COPD, chronic obstructive pulmonary disease; CT, computed tomography; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.

Close modal

CT Imaging Protocol

All patients underwent both chest low-radiation-dose CT in the supine position with their arms raised (Fig. 2a) and upright chest low-radiation-dose CT in the standing position with their arms lowered (Fig. 2b) in a randomized order within 1 h on the same day. The conventional and upright CT scans were performed using a conventional 320-detector-row CT (Aquilion ONE; Canon Medical Systems, Otawara, Japan) and upright 320-detector-row CT (prototype TSX-401R; Canon Medical Systems) [6, 7], respectively. These chest scans in the two positions were unenhanced and performed during both deep inspiration and expiration breath-holds with automatic exposure control using a noise index of 24 HU for a slice thickness of 5 mm (tube current range, 10–350 mA). Other scanning parameters were also the same for the supine and upright chest CT scans: peak tube voltage, 120 kVp; rotation speed, 0.5 s; slice collimation, 0.5 mm × 80; and pitch factor, 0.813. The series of contiguous 0.5-mm-thick images was reconstructed with adaptive iterative dose reduction 3D (Canon Medical Systems) [13].

Fig. 2.

Conventional CT examination in the supine position (a) and upright CT examination in the standing position (b). a Conventional CT in the supine position is performed with the patient’s arms raised during both deep inspiration and expiration breath-holds. b Upright CT in the standing position is performed with the patient’s arms lowered during both deep inspiration and expiration breath-holds. CT, computed tomography.

Fig. 2.

Conventional CT examination in the supine position (a) and upright CT examination in the standing position (b). a Conventional CT in the supine position is performed with the patient’s arms raised during both deep inspiration and expiration breath-holds. b Upright CT in the standing position is performed with the patient’s arms lowered during both deep inspiration and expiration breath-holds. CT, computed tomography.

Close modal

Pulmonary Function Tests

All participants underwent PFTs within 2 h on the same day that they underwent both conventional and upright CT examinations. PFTs were performed with the patient in a stable condition in the sitting position using a spirometer (Chestac-8900; Chest M.I., Tokyo, Japan), in accordance with American Thoracic Society/European Respiratory Society recommendations [14, 15]. Predicted values of spirometric measurements were derived from the guidelines of the Japanese Respiratory Society [16].

Lung, Lobe, and Airway Volume Measurements Using CT

Measurements of the lung, lobe, and airway volumes on both CT images of the 48 patients were performed by a chest radiologist with 15 years of experience using a commercially available workstation (Synapse Vincent; Fuji Film Co., Ltd., Tokyo, Japan) (Fig. 3) [7, 8, 12, 17-21]. This workstation incorporated a computer-aided detection system and automatically extracted the right and left lungs and the entire airway tree (from the trachea to all bilateral airways with lumen diameters of more than approximately 1.5 mm), defined as the airway volume [7, 8, 12, 17-21]. The workstation recognized lobar bronchi and determined the locations of fissures. The chest radiologist verified the computer-aided segmentation results and made manual corrections by delineating fissures when the computer-aided detection system failed to identify them properly, as previously described [7, 8, 17, 18]. To assess intra-observer agreement, a second measurement of the first 20 patients was performed 2 months after the first assessment by the same radiologist. To assess inter-observer agreement, the measurements of the volumes of the first 20 patients were performed by the other radiologist with 6 years of experience. All measurements were performed in a randomized and blinded manner. During all measurements, the radiologists were also blinded to patient characteristics and PFT results. The ratios of inspiratory to expiratory volumes on CT and the ratios of volumes in the standing position to those in the supine position were also calculated.

Fig. 3.

Representative lung, lobe, and airway volume measurements in a 77-year-old male patient with COPD. a Axial images. b Sagittal images. c Coronal images. d Volume rendering lung/lobe images. e Volume rendering airway images acquired in the supine and standing positions. Yellow, right upper lobe; blue, right middle lobe; green, right lower lobe; pink, left upper lobe; and purple, left lower lobe. COPD, chronic obstructive pulmonary disease.

Fig. 3.

Representative lung, lobe, and airway volume measurements in a 77-year-old male patient with COPD. a Axial images. b Sagittal images. c Coronal images. d Volume rendering lung/lobe images. e Volume rendering airway images acquired in the supine and standing positions. Yellow, right upper lobe; blue, right middle lobe; green, right lower lobe; pink, left upper lobe; and purple, left lower lobe. COPD, chronic obstructive pulmonary disease.

Close modal

Statistical Analysis

Data are presented as the mean ± standard deviation. The sample size calculation was based on postural changes in lung volume. The expected mean change in total lung volume (TLV) between the supine and standing positions was 400 mL, which was based on the postural change in a previous volunteer cohort [8], and we assumed the standard deviation of the change to be 830 mL. To detect clinically significant differences in CT-based volumes between the two positions with a significance level of 5% (two-tailed) and power of 90%, 48 patients were required. We estimated the dropout rate to be 5%; thus, the sample size was determined to be 51.

Paired t tests were performed to analyze the differences in the lung, lobe, and airway volumes and ratios of inspiratory to expiratory volumes between the supine and standing positions. The associations between CT volumes in each position and PFT measurements were evaluated using Pearson correlation coefficients. The difference in age between women and men was assessed using Student’s t test. Mann-Whitney U tests were performed to analyze the differences in age, height, weight, body mass index, and the ratios of the volumes in the standing position to those in the supine position between the GOLD 1 and GOLD 2–4 groups. Fisher’s exact test was used to compare sex between the GOLD 1 and GOLD 2–4 groups. Inter- and intra-observer agreements were evaluated by measuring intra-class correlation coefficients. The significance level for all tests was 5% (two-sided). All data were analyzed using a commercially available software program (JMP, version 12; SAS Institute Inc., Cary, NC, USA).

Participant Characteristics

The clinical characteristics of the 48 participants (mean age, 76.2 ± 7.5 years; 44 men) are shown in Table 1. No significant difference in age was observed between women and men (81.8 ± 4.4 vs. 75.7 ± 7.5 years, p = 0.1208).

Table 1.

Characteristics of the study population (48 patients with COPD)

Characteristics of the study population (48 patients with COPD)
Characteristics of the study population (48 patients with COPD)

Association between CT Volumes and PFT Measurements

The correlation coefficients (r) between the TLVs on inspiratory CT in the supine/standing position and the PFT total lung capacity and vital capacity were 0.887/0.920 (Fig. 4a) and 0.711/0.781 (Fig. 4b), respectively. The correlation coefficients between the TLVs on expiratory CT in the supine/standing position and the PFT functional residual capacity and residual volume were 0.676/0.744 (Fig. 4c) and 0.713/0.739 (Fig. 4d), respectively. The coefficients between the airway volume on inspiratory CT in the supine/standing position and the PFT FEV1 were 0.471/0.524, respectively (Fig. 4e).

Fig. 4.

Associations between CT volumes and pulmonary function test measurements. Scatterplots show the associations between (a) the total lung volumes (TLVs) on inspiratory CT in the supine/standing position and the PFT total lung capacity, (b) the TLVs on inspiratory CT in the supine/standing position and the PFT vital capacity, (c) the TLVs on expiratory CT in the supine/standing position and the PFT functional residual capacity, (d) the TLVs on expiratory CT in the supine/standing position and the PFT residual volume, and (e) the airway volumes on inspiratory CT in the supine/standing position and the PFT FEV1. Dotted lines show estimated regression. CT, computed tomography; FEV1, forced expiratory volume in 1 s; PFT, pulmonary function test.

Fig. 4.

Associations between CT volumes and pulmonary function test measurements. Scatterplots show the associations between (a) the total lung volumes (TLVs) on inspiratory CT in the supine/standing position and the PFT total lung capacity, (b) the TLVs on inspiratory CT in the supine/standing position and the PFT vital capacity, (c) the TLVs on expiratory CT in the supine/standing position and the PFT functional residual capacity, (d) the TLVs on expiratory CT in the supine/standing position and the PFT residual volume, and (e) the airway volumes on inspiratory CT in the supine/standing position and the PFT FEV1. Dotted lines show estimated regression. CT, computed tomography; FEV1, forced expiratory volume in 1 s; PFT, pulmonary function test.

Close modal

Lung, Lobe, and Airway Volumes on CT in Supine and Standing Positions

The average inspiratory volumes of the total lung (4.0% increase), right lung (3.9% increase), right upper lobe (4.6% increase), right lower lobe (6.9% increase), left lung (4.2% increase), left upper lobe (3.6% increase), left lower lobe (5.0% increase), and airway (4.6% increase) were significantly higher in the standing position than in the supine position (all p < 0.005) (Table 2). Additionally, the average expiratory volumes of the total lung (5.0% increase), right lung (5.7% increase), right upper lobe (15.5% increase), right lower lobe (6.1% increase), left lung (4.2% increase), left upper lobe (5.7% increase), and airway (21.2% increase) were significantly higher in the standing position than in the supine position (all p < 0.05) (Table 2). Conversely, the inspiratory and expiratory right middle lobe volumes were significantly lower in the standing position than in the supine position (4.6% and 15.9% decreases, respectively, both p < 0.001). No significant difference was found in the expiratory left lower lobe volume between the two positions (p = 0.4836). The average rates of decrease in airway volume from the standing position to the supine position on inspiratory and expiratory CTs were −4.4% and −17.5%, respectively. The average rates of decrease in airway volume from inspiration to expiration in the supine and standing positions were −36.9% and −26.9%, respectively.

Table 2.

Inspiratory and expiratory lung, lobe, and airway volumes on CT in the supine and standing positions (48 patients with COPD)

Inspiratory and expiratory lung, lobe, and airway volumes on CT in the supine and standing positions (48 patients with COPD)
Inspiratory and expiratory lung, lobe, and airway volumes on CT in the supine and standing positions (48 patients with COPD)

Ratio of Inspiratory Volume to Expiratory Volume in Supine and Standing Positions

The ratio of inspiratory volume to expiratory volume of the right middle lobe was significantly higher in the standing position than in the supine position (p < 0.0001); however, the ratios of inspiratory volumes to expiratory volumes of the right upper lobe and airway were significantly lower in the standing position than in the supine position (all p < 0.0001) (Table 3). No significant differences were observed in the ratio of inspiratory volume to expiratory volume of the total lung, right lung, right lower lobe, left lung, left upper lobe, and left lower lobe between the supine and standing positions (Table 3).

Table 3.

Ratio of inspiratory volume to expiratory volume on CT in the supine and standing positions (48 patients with COPD)

Ratio of inspiratory volume to expiratory volume on CT in the supine and standing positions (48 patients with COPD)
Ratio of inspiratory volume to expiratory volume on CT in the supine and standing positions (48 patients with COPD)

Ratio of Volume in Standing Position to Volume in Supine Position: GOLD 1 versus GOLD 2, 3, and 4

No significant differences were found in age, sex, height, weight, and body mass index between the GOLD 1 and GOLD 2–4 groups (online suppl. Table 1; see www.karger.com/doi/10.1159/000527067 for all online suppl. material). The ratios of the volumes in the standing position to those in the supine position of the inspiratory total lung, right lung, and left lung were significantly higher in the GOLD 1 group than in the GOLD 2–4 groups (all p < 0.03) (Table 4). No significant differences were found between the GOLD 1 and 2–4 groups in the ratios of the volumes in the standing position to those in the supine position of the expiratory total lung, right lung, left lung, all lobes, and airway (Table 4).

Table 4.

Ratio of volume in standing position to volume in supine position: GOLD 1 versus GOLD 2, 3, and 4

Ratio of volume in standing position to volume in supine position: GOLD 1 versus GOLD 2, 3, and 4
Ratio of volume in standing position to volume in supine position: GOLD 1 versus GOLD 2, 3, and 4

Inter-Observer and Intra-Observer Agreements

Inter- and intra-observer agreements (intra-class correlation coefficients) for measurements of CT volumes were 0.967–1.000 and 0.999–1.000, respectively.

This prospective study demonstrated that upright CT-based lung and airway volumes were more strongly correlated with PFT measurements than supine CT-based volumes in patients with COPD. This may be because PFTs are conducted in the upright position, and the direction of the thorax in PFTs corresponds to that in the upright CT rather than that in the conventional supine CT. Currently, no individual alternative is sufficient to replace conventional PFTs in all patients [5, 22]. However, our results suggest that, in addition to morphological evaluation of the chest, upright CT might be an alternative tool for predicting PFT measurements, such as total lung capacity, vital capacity, functional residual capacity, residual volume, and FEV1, in patients with COPD especially in situations where PFT cannot be performed. Upright CT could be a more accurate predictor of PFT measurements than conventional supine CT.

This study also demonstrated that the inspiratory volumes of the bilateral upper lobes, lower lobes, and lungs were significantly higher in the standing position than in the supine position, with the lower lobes exhibiting relatively greater changes. However, the inspiratory right middle lobe volume was significantly lower in the standing position than in the supine position. COPD seems to increase the risk of developing lung cancer [23, 24], and our findings would be important given their potential impact on preoperative CT volumetry of the lung and lobe in patients with COPD who have been diagnosed with lung cancer. Upright CT provides images of daily life postures and may be useful for a relatively more accurate pre-lobectomy (especially in lobectomy of the right middle lobe) prediction of postoperative residual pulmonary function in these patients. The reason for the lower inspiratory/expiratory right middle lobe volume in the standing position compared with that in the supine position is not immediately clear; however, the right middle lobe has a relatively small volume and is located in a relatively inferior and anterior portion of the right lung in the standing position. Therefore, the right middle lobe may be compressed by enlarged upper and lower lobes in the standing position, with volumes 2–3 times larger than that of the middle lobe [7].

In our study, patients with COPD exhibited average rates of increase in inspiratory and expiratory airway volumes from the supine to the standing position of 4.6% and 21.2%, respectively. In other words, the average rate of decrease in airway volume from the standing to the supine position on expiratory CT was larger than that on inspiratory CT (−17.5 vs. −4.4%). Furthermore, the average rate of decrease in airway volume from inspiration to expiration was larger in the supine position than in the standing position (−36.9 vs. −26.9%). In patients with COPD, breathing discomfort can become further amplified through adoption of the supine position (i.e., orthopnea) [25, 26]. In many individuals with COPD, orthopnea can be a problem at night and can disrupt sleep; however, the precise mechanisms underlying orthopnea remain unknown [26]. Eltayara et al. [25] reported that increased airway resistance in the supine position due to a lower end-expiratory lung volume probably plays a role in the genesis of orthopnea. Considering our results, the increased airway resistance in the supine position due to a lower expiratory airway volume could also play a role in the genesis of orthopnea.

Previous studies have compared lung volumes between the supine and standing positions in a volunteer cohort without any symptoms [7, 8]. They reported that the average percentage increase in the TLV in the standing position compared with that in the supine position was approximately 10%. This is numerically higher than that in the current COPD cohort (4%). Additionally, our results showed that the increase in the TLV in the standing position compared with that in the supine position in patients with mild COPD (GOLD 1) was significantly greater than that in patients with moderate and severe COPD (GOLD 2–4) (7 vs. 3%). This may be because of the loss of diaphragmatic mobility in patients with COPD [27].

There were some limitations to our study. First, we included only 48 patients (predominantly male, 92%) from a single institution with a relatively lower percentage of patients with severe COPD (only 13% were GOLD 3 and 2% were GOLD 4). Therefore, additional multi-center studies with a large population, containing an appropriate number of women and a representative percentage of patients with severe COPD, are needed to confirm our preliminary results. Second, although the observers independently assessed the CT images in a randomized and blinded manner, they could recognize patients’ positions to some extent because of the absence or existence of CT tables. However, the volume measurements were semi-automatic due to the use of a commercially available workstation; thus, observer bias would have been nonsignificant. In addition, the inter- and intra-observer agreements (intra-class correlation coefficients) in this study were high (>0.96). Third, we performed the PFTs in the upright position but not in the supine position; therefore, we could not evaluate the correlations between the volumes on supine CT and measurements on supine PFT. Fourth, in this study, upright CT was performed with arms lowered, whereas conventional supine CT was performed with arms raised; thus, the form of the chest would have been slightly different between upright and supine positions, which may have influenced the results of this study. However, we believe that standing with the arms lowered is the natural standing posture for humans.

Upright CT-based lung and airway volumes were more correlated with PFT measurements than supine CT-based volumes in patients with COPD. Thus, upright CT may be a relatively more reliable alternative tool for predicting PFT measurements when PFTs cannot be performed. The inspiratory and expiratory bilateral upper lobes, right lower lobe, right lung, left lung, and airway volumes were significantly higher in the standing position than in the supine position; however, the inspiratory and expiratory right middle lobe volumes were significantly lower in the standing position. Our findings indicate that upright CT may be more reliable than supine CT for pre-lobectomy predictions of postoperative residual pulmonary function in patients with COPD who have been diagnosed with lung cancer.

The authors acknowledge Dr. Yasunori Sato, Ms. Naomi Tamaki, Ms. Yoko Tauchi, and Ms. Kyoko Komatsu for their valuable assistance.

This study was conducted in accordance with the amended Declaration of Helsinki. This study protocol was reviewed and approved by Keio University School of Medicine Ethics Committee, approval number 20160385. Written informed consent was obtained from all participants.

Masahiro Jinzaki has received a grant from Canon Medical Systems. However, Canon Medical Systems was not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, and approval of the manuscript. The remaining authors have no conflicts of interest to declare.

This study was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant No. JP20K08056 and JP17K16482). The funder had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

Yoshitake Yamada, Shotaro Chubachi, and Masahiro Jinzaki were responsible for the conception or design of the work; Yoshitake Yamada, Shotaro Chubachi, Minoru Yamada, Yoichi Yokoyama, Akiko Tanabe, Shiho Matsuoka, and Yuki Niijima were responsible for the acquisition of data; Yoshitake Yamada, Shotaro Chubachi, Minoru Yamada, and Yoichi Yokoyama analyzed and interpreted the data; Yoshitake Yamada, Shotaro Chubachi, Minoru Yamada, Yoichi Yokoyama, Akiko Tanabe, Shiho Matsuoka, Yuki Niijima, Mitsuru Murata, Koichi Fukunaga, and Masahiro Jinzaki drafted or revised the paper for important intellectual content and final approval of data

All data generated or analyzed during this study are included in this article and its online supplementary material. Further inquiries can be directed to the corresponding author.

1.
Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary.
Am J Respir Crit Care Med
. 2017 Mar 1;195(5):557–82.
2.
World Health Organization. The top 10 causes of death. World Health Organization Web site [updated 2020 Dec 6]. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. (accessed June 1, 2022).
3.
Bodduluri S, Reinhardt JM, Hoffman EA, Newell JD Jr, Bhatt SP. Recent advances in computed tomography imaging in chronic obstructive pulmonary disease.
Ann Am Thorac Soc
. 2018 Mar;15(3):281–9.
4.
Johns Hopkins University Center for Systems Science and Engineering (CSSE). COVID-19 dashboard. Johns Hopkins University & Medicine Web site. Available from: https://coronavirus.jhu.edu/map.html (accessed June 1, 2022).
5.
Kouri A, Gupta S, Yadollahi A, Ryan CM, Gershon AS, To T, et al. Addressing reduced laboratory-based pulmonary function testing during a pandemic.
Chest
. 2020 Dec;158(6):2502–10.
6.
Jinzaki M, Yamada Y, Nagura T, Nakahara T, Yokoyama Y, Narita K, et al. Development of upright computed tomography with area detector for whole-body scans: phantom study, efficacy on workflow, effect of gravity on human body, and potential clinical impact.
Invest Radiol
. 2020 Feb;55(2):73–83.
7.
Yamada Y, Yamada M, Yokoyama Y, Tanabe A, Matsuoka S, Niijima Y, et al. Differences in lung and lobe volumes between supine and standing positions scanned with conventional and newly developed 320-detector-row upright CT: intra-individual comparison.
Respiration
. 2020 Jul 8;99(7):598–605.
8.
Yamada Y, Yamada M, Chubachi S, Yokoyama Y, Matsuoka S, Tanabe A, et al. Comparison of inspiratory and expiratory lung and lobe volumes among supine, standing, and sitting positions using conventional and upright CT.
Sci Rep
. 2020 Oct 1;10(1):16203.
9.
Kauczor HU, Heussel CP, Fischer B, Klamm R, Mildenberger P, Thelen M. Assessment of lung volumes using helical CT at inspiration and expiration: comparison with pulmonary function tests.
AJR Am J Roentgenol
. 1998 Oct;171(4):1091–5.
10.
Becker MD, Berkmen YM, Austin JH, Mun IK, Romney BM, Rozenshtein A, et al. Lung volumes before and after lung volume reduction surgery: quantitative CT analysis.
Am J Respir Crit Care Med
. 1998 May;157(5 Pt 1):1593–9.
11.
Brown MS, Kim HJ, Abtin F, Da Costa I, Pais R, Ahmad S, et al. Reproducibility of lung and lobar volume measurements using computed tomography.
Acad Radiol
. 2010 Mar;17(3):316–22.
12.
Chubachi S, Yamada Y, Yamada M, Yokoyama Y, Tanabe A, Matsuoka S, et al. Differences in airway lumen area between supine and upright computed tomography in patients with chronic obstructive pulmonary disease.
Respir Res
. 2021 Mar 31;22(1):95.
13.
Yamada Y, Jinzaki M, Hosokawa T, Tanami Y, Sugiura H, Abe T, et al. Dose reduction in chest CT: comparison of the adaptive iterative dose reduction 3D, adaptive iterative dose reduction, and filtered back projection reconstruction techniques.
Eur J Radiol
. 2012 Dec;81(12):4185–95.
14.
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry.
Eur Respir J
. 2005 Aug;26(2):319–38.
15.
Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 update. An ffficial American Thoracic Society and European Respiratory Society technical statement.
Am J Respir Crit Care Med
. 2019 Oct 15;200(8):e70–88.
16.
The Committee of Pulmonary Physiology, Japanese Respiratory Society. Forced expiratory curve, flow volume curve and peak flow. 8th ed.
The clinical respiratory function test
. Medical review. Tokyo: Japanese Respiratory Society; 2016. p. 312–321. (Japanese).
17.
Iwano S, Kitano M, Matsuo K, Kawakami K, Koike W, Kishimoto M, et al. Pulmonary lobar volumetry using novel volumetric computer-aided diagnosis and computed tomography.
Interact Cardiovasc Thorac Surg
. 2013 Jul;17(1):59–65.
18.
Kitano M, Iwano S, Hashimoto N, Matsuo K, Hasegawa Y, Naganawa S. Lobar analysis of collapsibility indices to assess functional lung volumes in COPD patients.
Int J Chron Obstruct Pulmon Dis
. 2014;9:1347–56.
19.
Tanabe N, Shima H, Sato S, Oguma T, Kubo T, Kozawa S, et al. Direct evaluation of peripheral airways using ultra-high-resolution CT in chronic obstructive pulmonary disease.
Eur J Radiol
. 2019 Nov;120:108687.
20.
Tanabe N, Sato S, Oguma T, Shima H, Sato A, Muro S, et al. Associations of airway tree to lung volume ratio on computed tomography with lung function and symptoms in chronic obstructive pulmonary disease.
Respir Res
. 2019 Apr 18;20(1):77.
21.
Matsumoto S, Yamada Y, Yamada M, Chubachi S, Yokoyama Y, Matsuoka S, et al. Difference in the airway luminal area between the standing and supine positions using upright and conventional computed tomography.
Clin Anat
. 2021 Nov;34(8):1150–6.
22.
Crimi C, Impellizzeri P, Campisi R, Nolasco S, Spanevello A, Crimi N. Practical considerations for spirometry during the COVID-19 outbreak: literature review and insights.
Pulmonology
. 2021 Sep–Oct;27(5):438–47.
23.
Mouronte-Roibás C, Leiro-Fernández V, Fernández-Villar A, Botana-Rial M, Ramos-Hernández C, Ruano-Ravina A. COPD, emphysema and the onset of lung cancer. A systematic review.
Cancer Lett
. 2016 Nov 28;382(2):240–4.
24.
Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.
Eur Respir J
. 2009 Aug;34(2):380–6.
25.
Eltayara L, Ghezzo H, Milic-Emili J. Orthopnea and tidal expiratory flow limitation in patients with stable COPD.
Chest
. 2001 Jan;119(1):99–104.
26.
Elbehairy AF, Faisal A, McIsaac H, Domnik NJ, Milne KM, James MD, et al. Mechanisms of orthopnoea in patients with advanced COPD.
Eur Respir J
. 2021 Mar;57(3):2000754.
27.
Hida T, Yamada Y, Ueyama M, Araki T, Nishino M, Kurosaki A, et al. Decreased and slower diaphragmatic motion during forced breathing in severe COPD patients: time-resolved quantitative analysis using dynamic chest radiography with a flat panel detector system.
Eur J Radiol
. 2019 Mar;112:28–36.
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.